JonathanChouMDPhD

Oncology • San Francisco, CA

Genitourinary Oncology

Assistant Professor of Medicine, Hematology/Oncology

Join to view full profile

Dr. Chou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chou's full profile

Already have an account?

Office
1825 4th St, 6th Floor
San Francisco, CA 94158
Phone+1 415-476-4616

Summary

Dr. Jonathan Chou is an oncologist in San Francisco, CA and is affiliated with UCSF Medical Center. He received his medical degree from University of California (San Francisco) School of Medicine. He specializes in genitourinary oncology and is experienced in prostate cancer, kidney cancer, bladder cancer, and testicular cancer.

Education & Training

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2016 - 2019
University of California (San Francisco)Residency, Internal Medicine, 2014 - 2016
University of California San Francisco School of MedicineMD, PhD

Certifications & Licensure

CA State Medical License 2016 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors.
Jonathan Chou, Troy M Robinson, Emily A Egusa, Roshan Lodha, Meng Zhang
Clinical Cancer Research. 2024-12-02
1 citations
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13.
Jean Ching-Yi Tien, Jie Luo, Yu Chang, Yuping Zhang, Yunhui Cheng
Cell Reports. Medicine. 2024-10-15
PET Imaging Using 89Zr Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention (EPR) in Prostate Cancer.
Niranjan Meher, Anil P Bidkar, Anju Wadhwa, Kondapa Naidu Bobba, Suchi Dhrona
Molecular Cancer Therapeutics. 2024-09-27

Press Mentions

The Prostate Cancer Foundation Announces 2020 Young Investigator Awards Totaling $6 Million for Prostate Cancer ResearchDecember 16th, 2020

External Links

Chou lab websitehttp://jonchoulab.com